Zucero

The startup is developing small molecule drugs that target viral infections and modulate the innate immune system to enhance its response to diseases. This approach aims to improve human health by addressing the challenges posed by serious viral diseases.

Melbourne, Australia

Updated 2 months ago

Funding

$6.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

The startup is developing small molecule drugs that target viral infections and modulate the innate immune system to enhance its response to diseases. This approach aims to improve human health by addressing the challenges posed by serious viral diseases.